CN Patent

CN116270647B — 利匹韦林在制备抗h1n1亚型猪流感病毒药物中的应用

Assigned to Institute Animal Science and Veterinary Medicine of Shandong AAS · Expires 2025-06-20 · 1y expired

What this patent protects

本发明属于医药技术领域，具体涉及利匹韦林在制备抗H1N1亚型猪流感病毒药物中的应用。本发明首次发现化合物利匹韦林能够有效抑制H1N1亚型猪流感病毒的增殖，且对细胞的毒性较小，经实验证明，利匹韦林在体外实验PK15细胞模型上能够有效抑制和杀灭H1N1亚型猪流感病毒，能够有效抑制H1N1亚型猪流感病毒的入侵，且细胞毒性较小，可作为一类新的抗H1N1亚型猪流感病毒的药物，为利匹韦林开辟了新的药物用途，也为开发高效特异的抗H1N1亚型猪流感病毒药物奠定实验基础并提供新的视野。

USPTO Abstract

本发明属于医药技术领域，具体涉及利匹韦林在制备抗H1N1亚型猪流感病毒药物中的应用。本发明首次发现化合物利匹韦林能够有效抑制H1N1亚型猪流感病毒的增殖，且对细胞的毒性较小，经实验证明，利匹韦林在体外实验PK15细胞模型上能够有效抑制和杀灭H1N1亚型猪流感病毒，能够有效抑制H1N1亚型猪流感病毒的入侵，且细胞毒性较小，可作为一类新的抗H1N1亚型猪流感病毒的药物，为利匹韦林开辟了新的药物用途，也为开发高效特异的抗H1N1亚型猪流感病毒药物奠定实验基础并提供新的视野。

Drugs covered by this patent

Patent Metadata

Patent number: CN116270647B
Jurisdiction: CN
Classification: —
Expires: 2025-06-20
Drug substance claim: No
Drug product claim: No
Assignee: Institute Animal Science and Veterinary Medicine of Shandong AAS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.